We source, fund, govern, support, and incubate translational research in women's health.
We believe in a systems biology approach to research. However, to best evaluate the science we take a cohort approach to funding projects.
It's affected by many factors, including genetics, BMI, environmental factors, therapies and health conditions. Progress lies in doing research to get at the underlying causes of reproductive decline in women.
Understanding what factors cause menopause and the related health outcomes that come with it is a way into the future still
Despite oncology receiving most biomedical funding, gynecologic oncology has been left behind. Uterine, ovarian, cervical, and rare gynecologic cancers are usually diagnosed late, and survivors face infertility after current treatments.
We have only just scratched the surface of scientific research on endometriosis and PCOS - especially since these areas have been written in the context of other conditions.
Fertility research is a crucial endeavor aimed at unraveling the intricate factors that influence reproductive capacity in women that enables the development of personalized interventions.
Smooth muscle tumours that grow in the uterus from the muscle layers of the womb. Endometriosis can cause infertility and oocyte quality drop.
Dr. Mario Cordero, Principal Investigator at Universidad Pablo de Olavide, Sevilla (UPO) is working on the Diminished ovarian reserve (DOR) is an overlooked issue that currently lacks effective treatment.View Project
By harnessing the potential of the ISR pathway, we open doors to innovative interventions that could prolong ovarian function and reduce risks of Primary Ovarian Insufficiency.View Project
Ovom Care is a digital-first clinic providing you seamless access to care, information, and support whenever and wherever you are - throughout your journey. Ovom Care was co-founded by Dr. Lynae Brayboy, Felicia von Reden, and Dr. Cristina Hickman.View Project
Last year, we published our landmark Reproductive Health Report - Vol I, which established where reproductive biology is today in the critical topic of Ovarian Aging.
Building upon the positive response and recognizing the urgent need for further awareness, we decided to make this a series and proudly present Volume II, dedicated to two prevalent overlooked conditions: Polycystic Ovary Syndrome (PCOS) and Endometriosis. These conditions not only affect the lives of countless women worldwide but also highlight the imperative role of patient and advocate-led initiatives.